FDA Approvals - Addition of Thalidomide to Standard Therapy Improves Overall Survival in
Addition of Thalidomide to Standard Therapy Improves Overall Survival in Newly Diagnosed Multiple Myeloma (RedNova)
BOULDER, Colo., June 4 /PRNewswire-FirstCall/
Novartis' biogeneric wins breakthrough approval from FDA (Pharmaceutical Business Review)
In a landmark decision the FDA has approved Novartis biogeneric drug Omnitrope for the treatment of growth disorders in children and adults.